These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35138147)

  • 1. Axillary Microbiota Is Associated with Cognitive Impairment in Parkinson's Disease Patients.
    Arikan M; Yildiz Z; Kahraman Demir T; Yilmaz NH; Sen A; Hanoglu L; Yildirim S
    Microbiol Spectr; 2022 Feb; 10(1):e0235821. PubMed ID: 35138147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
    Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
    Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort.
    Jones JD; Kuhn TP; Szymkowicz SM
    Parkinsonism Relat Disord; 2018 Feb; 47():3-7. PubMed ID: 29233608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment in Parkinson's disease.
    Martinez-Horta S; Kulisevsky J
    J Neural Transm (Vienna); 2019 Jul; 126(7):897-904. PubMed ID: 30963293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia and cognitive impairment in patients with Parkinson's disease from India: a 7-year prospective study.
    Sanyal J; Banerjee TK; Rao VR
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):630-6. PubMed ID: 24771763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementia.
    Martin RC; Triebel KL; Kennedy RE; Nicholas AP; Watts RL; Stover NP; Brandon M; Marson DC
    Parkinsonism Relat Disord; 2013 Nov; 19(11):986-90. PubMed ID: 23899743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
    Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
    Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson's disease.
    Loureiro D; Bilbao R; Bordet S; Grasso L; Otero-Losada M; Capani F; Ponzo OJ; Perez-Lloret S
    Neurol Sci; 2023 Apr; 44(4):1211-1222. PubMed ID: 36542202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling Parkinson's disease cognitive phenotypes via resting-state magnetoencephalography.
    Simon OB; Rojas DC; Ghosh D; Yang X; Rogers SE; Martin CS; Holden SK; Kluger BM; Buard I
    J Neurophysiol; 2022 Jan; 127(1):279-289. PubMed ID: 34936515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
    Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
    J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease.
    Kamble N; Bhattacharya A; Hegde S; Vidya N; Gothwal M; Yadav R; Pal PK
    Behav Brain Res; 2022 Mar; 422():113733. PubMed ID: 34998797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome contributes to cognitive impairment in patients with Parkinson's disease.
    Peng Z; Dong S; Tao Y; Huo Y; Zhou Z; Huang W; Qu H; Liu J; Chen Y; Xu Z; Wang Y; Zhou H
    Parkinsonism Relat Disord; 2018 Oct; 55():68-74. PubMed ID: 29908727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.